SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
8564629
Source:
http://linkedlifedata.com/resource/pubmed/id/8564629
Search
Subject
(
54
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0004048
,
umls-concept:C0032861
,
umls-concept:C0073992
,
umls-concept:C0079043
,
umls-concept:C2926735
pubmed:issue
1
pubmed:dateCreated
1996-3-1
pubmed:abstractText
The protective effect of a new long acting beta 2-agonist, salmeterol, against exercise-induced bronchoconstriction has been documented when given as inhaled aerosol.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9503580
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Agonists
,
http://linkedlifedata.com/resource/pubmed/chemical/Albuterol
,
http://linkedlifedata.com/resource/pubmed/chemical/Bronchodilator Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Powders
,
http://linkedlifedata.com/resource/pubmed/chemical/salmeterol
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1081-1206
pubmed:author
pubmed-author:BrattenGG
,
pubmed-author:HenriksenA HAH
,
pubmed-author:SchaanningJJ
,
pubmed-author:VilsvikJJ
pubmed:issnType
Print
pubmed:volume
76
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
57-60
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:8564629-Administration, Inhalation
,
pubmed-meshheading:8564629-Adolescent
,
pubmed-meshheading:8564629-Adrenergic beta-Agonists
,
pubmed-meshheading:8564629-Adult
,
pubmed-meshheading:8564629-Albuterol
,
pubmed-meshheading:8564629-Asthma, Exercise-Induced
,
pubmed-meshheading:8564629-Bronchoconstriction
,
pubmed-meshheading:8564629-Bronchodilator Agents
,
pubmed-meshheading:8564629-Cross-Over Studies
,
pubmed-meshheading:8564629-Double-Blind Method
,
pubmed-meshheading:8564629-Exercise Test
,
pubmed-meshheading:8564629-Female
,
pubmed-meshheading:8564629-Humans
,
pubmed-meshheading:8564629-Male
,
pubmed-meshheading:8564629-Middle Aged
,
pubmed-meshheading:8564629-Peak Expiratory Flow Rate
,
pubmed-meshheading:8564629-Powders
,
pubmed-meshheading:8564629-Time Factors
pubmed:year
1996
pubmed:articleTitle
Efficacy and duration of salmeterol powder inhalation in protecting against exercise-induced bronchoconstriction.
pubmed:affiliation
Dept. of Pulmonary Diseases, Regional Hospital, University of Trondheim, Norway.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Randomized Controlled Trial